Reference Ranges for Testosterone in Men Generated Using Liquid Chromatography Tandem Mass Spectrometry in a Community-Based Sample of Healthy Nonobese Young Men in the Framingham Heart Study and Applied to Three Geographically Distinct Cohorts
Top Cited Papers
Open Access
- 1 August 2011
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 96 (8), 2430-2439
- https://doi.org/10.1210/jc.2010-3012
Abstract
Context: Reference ranges are essential for partitioning testosterone levels into low or normal and making the diagnosis of androgen deficiency. We established reference ranges for total testosterone (TT) and free testosterone (FT) in a community-based sample of men. Methods: TT was measured using liquid chromatography tandem mass spectrometry in nonobese healthy men, 19–40 yr old, in the Framingham Heart Study Generation 3; FT was calculated. Values below the 2.5th percentile of reference sample were deemed low. We determined the association of low TT and FT with physical dysfunction, sexual symptoms [European Male Aging Study (EMAS) only], and diabetes mellitus in three cohorts: Framingham Heart Study generations 2 and 3, EMAS, and the Osteoporotic Fractures in Men Study. Results: In a reference sample of 456 men, mean (sd), median (quartile), and 2.5th percentile values were 723.8 (221.1), 698.7 (296.5), and 348.3 ng/dl for TT and 141. 8 (45.0), 134.0 (60.0), and 70.0 pg/ml for FT, respectively. In all three samples, men with low TT and FT were more likely to have slow walking speed, difficulty climbing stairs, or frailty and diabetes than those with normal levels. In EMAS, men with low TT and FT were more likely to report sexual symptoms than men with normal levels. Men with low TT and FT were more likely to have at least one of the following: sexual symptoms (EMAS only), physical dysfunction, or diabetes. Conclusion: Reference ranges generated in a community-based sample of men provide a rational basis for categorizing testosterone levels as low or normal. Men with low TT or FT by these criteria had higher prevalence of physical dysfunction, sexual dysfunction, and diabetes. These reference limits should be validated prospectively in relation to incident outcomes and in randomized trials.Keywords
This publication has 53 references indexed in Scilit:
- Evidence for Geographical and Racial Variation in Serum Sex Steroid Levels in Older MenJournal of Clinical Endocrinology & Metabolism, 2010
- Free Testosterone Levels Are Associated with Mobility Limitation and Physical Performance in Community-Dwelling Men: The Framingham Offspring StudyJournal of Clinical Endocrinology & Metabolism, 2010
- Sex Hormones and Frailty in Older Men: The Osteoporotic Fractures in Men (MrOS) StudyJournal of Clinical Endocrinology & Metabolism, 2009
- The Effects of Serum Testosterone, Estradiol, and Sex Hormone Binding Globulin Levels on Fracture Risk in Older MenJournal of Clinical Endocrinology & Metabolism, 2009
- Metabolic and Reproductive Features before and during Puberty in Daughters of Women with Polycystic Ovary SyndromeJournal of Clinical Endocrinology & Metabolism, 2009
- Contemporary Trends in Dyslipidemia in the Framingham Heart StudyJAMA Internal Medicine, 2009
- Association Between Testosterone and Estradiol and Age‐Related Decline in Physical Function in a Diverse Sample of MenJournal of the American Geriatrics Society, 2008
- Physical Performance and Risk of Hip Fractures in Older MenJournal of Bone and Mineral Research, 2008
- Sex Differences of Endogenous Sex Hormones and Risk of Type 2 DiabetesJAMA, 2006
- Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study — A large observational study of the determinants of fracture in older menContemporary Clinical Trials, 2005